ACAnn Yi-Chiun Chuang

Ann Yi-Chiun Chuang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ann Yi-Chiun Chuang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Che-Yu Lin

    Department of Medical Education, MacKay Memorial Hospital, Taipei,Taiwan

    1 shared publication
  • Cher-Ming Liou

    Department of Anesthesiology, Chung Shan Medical University Hospital, Chung Shan Medical University, No. 110, Section 1, Jianguo North Road, Taichung City, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

    1 shared publication
  • Hsin-Ming Liu

    Department of Ophthalmology, Mackay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Zhongshan Dist., Taipei City, Taiwan; Cochrane Taiwan, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei City, Taiwan

    1 shared publication
  • S L Liao

    Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan

    1 shared publication
  • Shannon Su

    Department of Emory University School of Medicine, Atlanta, GA, USA

    1 shared publication
  • Shannon Su

    Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA 30307, USA

    1 shared publication

Latest Publications

  • Open Access

    Remission of myasthenia gravis following infection with SARS-CoV-2

    by Che-Yu Lin, Shannon Su, Ann Yi-Chiun Chuang

    This case report describes an unprecedented remission of ocular Myasthenia Gravis (MG) in a 3-year-old girl following a SARS-CoV-2 infection. Both MG and SARS-CoV-2 influence the cholinergic system, and this case underscores the importance of considering multiple factors in autoimmune disorders and the potential impact of viral infections on their course. The patient initially presented with ptosis and limited eye movement. Her diagnosis of seronegative MG was confirmed with abnormal visual evoked potentials and positive response to pyridostigmine. Her ptosis and limited extraocular muscle movement were intermittent until 2 years later when she tested positive for SARS-CoV-2 for which no antiviral medication was taken. Unexpectedly, her MG symptoms rapidly improved postinfection, leading to the cessation of pyridostigmine. This case highlights the complex interplay between MG, viral infections, and the influence of anti-acetylcholine receptor antibodies, second-hand smoke, and natural nicotinic agonists from the use of pyridostigmine on the cholinergic system.

  • The role of rectus muscle myectomy in the management of large-angle strabismus for Graves’ ophthalmopathy

    by S L Liao, Y-H Wei, A Y-C Chuang

    PurposeRetrospective noncomparative case series to investigate the role of rectus muscle myectomy for the treatment of large-angle strabismus in patients with Graves' ophthalmopathy.Patients and methodsData from 47 consecutive patients with Graves' ophthalmopathy who underwent complete myectomy for large-angle strabismus (strabismus greater than 25 prism diopters (PDs)) were collected retrospectively. Pre- and postoperative deviations in primary and reading position were measured in PDs. Postoperative deviation of <5 diopters in primary gaze and functional binocular vision in central 30° field were considered as successful surgical outcomes.ResultsPatients undergoing complete myectomy of the restricted muscles in large-angle strabismus achieved a 78.7% success rate after the first surgery. Reoperation performed on seven patients resulted in 85.7% success rate in reoperation group. The overall success rate was 91.5%. The mean efficacy of the isolated rectus muscle myectomy was 34.3±7.7 PDs.ConclusionsThe complete rectus muscle myectomy technique is effective and predictable in the treatment of large-angle strabismus in patients with Graves' ophthalmopathy.


  • Open Access

    How to effectively manage myopia

    by Ann Yi-Chiun Chuang

    Myopia has become epidemic in the world. Without effective control, the progression may lead to excessive myopia with severe complications affecting vision and ocular alignment. The genetic factors and environmental factors of myopia are closely interrelated to each other. Asian ethnicity and parental myopia, among other genetic factors, influence the refractive outcome dramatically when environmental risk factors such as hours of near work and reading distance are analyzed. Outdoor activities are protective measures that retard myopia progression. Total time under the sun and not the specific outdoor activities are contributing factors. Current effective treatments for myopia include atropine of high, moderate, and low doses, relative peripheral myopia-inducing devices, and bifocal spectacles including prism bifocal spectacle lenses. Although atropine is considered highly effective in randomized controlled trials, it is not well tolerated in a clinical setting, especially in high dosage. Since the severity of rebound effect of atropine after cessation of usage and the side effects are directly related to the concentration of the medication, it is recommended that low-dose atropine is used in the initial attempt. Higher concentration for better control can be considered when compliance is observed. Devices that induce relative peripheral myopia such as orthokeratology are moderately effective interventions that are well accepted by children who wish to be spectacle free. Bifocal spectacles generally have low effect in myopia control. Prism bifocal spectacle lenses may have a special niche in myopia retardation for patients with low lags of accommodation.


  • Open Access

    Various Modifications of Müller's Muscle-Conjunctival Resection for Ptosis Repair

    by Shu-Lang Liao, Ann Yi-Chiun Chuang

    Liao SL, et al. Arch Aesthetic Plast Surg. 2015 Jun;21(2):31-36. http://dx.doi.org/10.14730/aaps.2015.21.2.31